Endogenous GLP-1 alters postprandial functional connectivity between homeostatic and reward-related brain regions involved in regulation of appetite in healthy lean males: A pilotstudy

Diabetes Obes Metab. 2018 Oct;20(10):2330-2338. doi: 10.1111/dom.13369. Epub 2018 Jun 10.

Abstract

Aims: Peripheral infusion of glucagon-like peptide-1 (GLP-1) can affect brain activity in areas involved in the regulation of appetite, including hypothalamic and reward-related brain regions. In contrast, the physiological role of endogenous GLP-1 in the central regulation of appetite has hardly been investigated.

Materials and methods: This was a randomized, cross-over trial that involved 12 healthy volunteers who received an intragastric (ig) glucose (gluc) load, with or without intravenous (iv) exendin9-39 (ex9-39; specific GLP-1 receptor antagonist). Functional magnetic resonance imaging was used to investigate the effect of endogenous GLP-1 on resting state functional connectivity (rsFC) between homeostatic and reward-related brain regions. Visual analogue scales were used to rate appetite-related sensations. Blood samples were collected for GI hormone measurements.

Results: Administration of iv-ex9-39/ig-gluc induced a significantly higher rsFC, relative to ig-gluc administration, between the hypothalamus and the left lateral orbitofrontal cortex (OFC) as well as the left amygdala (P ≤ .001, respectively). Administration of iv-ex9-39/ig-gluc induced a significantly higher rsFC, relative to ig-gluc administration, between the right nucleus accumbens and the right lateral OFC (P < .001). Administration of iv-ex9-39/ig-gluc induced a significantly lower rsFC, relative to ig-gluc administration, between the midbrain and the right caudate nucleus (P = .001). Administration of ig-gluc significantly decreased prospective food consumption and increased sensations of fullness compared to pre-infusion baseline (P = .028 and P = .019, respectively); these effects were not present in the iv-ex9-39/ig-gluc condition.

Conclusions: This pilot trial provides preliminary experimental evidence that glucose-induced endogenous GLP-1 affects central regulation of appetite by modulating rsFC in homeostatic and reward-related brain regions in healthy lean male participants in a GLP-1 receptor-mediated fashion.

Keywords: central regulation of appetite; exendin9-39; glucagon-like peptide-1; homeostatic brain regions; resting state functional connectivity; reward-related brain regions.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Appetite / drug effects
  • Appetite Regulation* / drug effects
  • Brain / drug effects
  • Brain / physiology*
  • Cross-Over Studies
  • Glucagon-Like Peptide 1 / blood
  • Glucagon-Like Peptide 1 / physiology*
  • Glucose / administration & dosage
  • Glucose / pharmacology
  • Healthy Volunteers
  • Homeostasis / drug effects
  • Humans
  • Male
  • Nerve Net / drug effects
  • Peptide Fragments / pharmacology*
  • Pilot Projects
  • Postprandial Period / drug effects
  • Reward*
  • Thinness* / blood
  • Thinness* / metabolism
  • Thinness* / physiopathology
  • Thinness* / psychology
  • Young Adult

Substances

  • Peptide Fragments
  • exendin (9-39)
  • Glucagon-Like Peptide 1
  • Glucose